|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 38/1709 | (2013.01) | ||
| A61K 9/19 | (2006.01) | ||
| A61K 38/2242 | (2013.01) | ||
| A61K 38/17 | (2006.01) | ||
| A61K 9/19 | (2013.01) | ||
| A61K 38/22 | (2006.01) | ||
| A61K 9/0019 | (2013.01) | ||
| A61K 47/12 | (2006.01) | ||
| A61K 47/12 | (2013.01) | ||
| A61K 47/20 | (2006.01) | ||
| A61K 47/26 | (2013.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61K 47/20 | (2013.01) | ||
| A61P 19/08 | (2006.01) | ||
| A61P 19/08 | (2018.01) |
| (11) | Number of the document | 3328416 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16750584.1 |
| Date of filing the European patent application | 2016-08-01 | |
| (97) | Date of publication of the European application | 2018-06-06 |
| (45) | Date of publication and mention of the grant of the patent | 2024-03-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/044968 |
| Date | 2016-08-01 |
| (87) | Number | WO 2017/020034 |
| Date | 2017-02-02 |
| (30) | Number | Date | Country code |
| 201562199081 P | 2015-07-30 | US | |
| 201662320704 P | 2016-04-11 | US |
| (72) |
BULLENS, Sherry , US
BUNTING, Stuart , US
CHOU, Tianwei , US
OKHAMAFE, Augustus, O. , US
PRICE, Christopher, P. , DE
WENDT, Daniel, J. , US
YAP, Clarence , US
|
| (73) |
BioMarin Pharmaceutical Inc. ,
105 Digital Drive, Novato, CA 94949,
US
|
| (54) | USE OF C-TYPE NATRIURETIC PEPTIDE VARIANTS TO TREAT SKELETAL DYSPLASIA |
| USE OF C-TYPE NATRIURETIC PEPTIDE VARIANTS TO TREAT SKELETAL DYSPLASIA |